LADENBURG THALMANN FINANCIAL SERVICES INC. - DIFFUSION PHARMACEUTICALS IN ownership

DIFFUSION PHARMACEUTICALS IN's ticker is and the CUSIP is 253748305. A total of 12 filers reported holding DIFFUSION PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of DIFFUSION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$0
-100.0%
8000.0%0.00%
Q3 2019$1,000
-50.0%
8000.0%0.00%
Q2 2019$2,000
-33.3%
8000.0%0.00%
Q1 2019$3,0008000.00%
Other shareholders
DIFFUSION PHARMACEUTICALS IN shareholders Q1 2019
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 468,620$1,336,0001.68%
Anson Funds Management LP 654,762$1,866,0000.47%
Swift Run Capital 14,545$41,0000.04%
Virtu Financial LLC 11,864$34,0000.00%
Advisor Group, Inc. 940$3,0000.00%
PNC FINANCIAL SERVICES GROUP, INC. 667$2,0000.00%
WELLS FARGO & COMPANY/MN 149,875$427,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 10,060$28,0000.00%
DEUTSCHE BANK AG\ 200$00.00%
View complete list of DIFFUSION PHARMACEUTICALS IN shareholders